Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects

NCT07490353 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Depression - Major Depressive Disorder
Anhedonia

Interventions

DRUG: Psilocybin (Usona Institute)
DRUG: Risperidone 1 MG
DIAGNOSTIC_TEST: MRI

Sponsor

Medical University of Vienna

Collaborators

[object Object]